Cell-to-cell variability in inducible Caspase9-mediated cell death

[1]  L. Coin,et al.  Phase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T Cells , 2019, Clinical Cancer Research.

[2]  C. Richards,et al.  Quantitative epigenetics and evolution , 2018, Heredity.

[3]  E. Horwitz,et al.  Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy , 2018, Cancer Gene Therapy.

[4]  H. Boulaiz,et al.  Cancer suicide gene therapy: a patent review , 2016, Expert opinion on therapeutic patents.

[5]  G. Lahav,et al.  Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing , 2016, Cell.

[6]  H. Neumann,et al.  Axial contraction and short-range compaction of chromatin synergistically promote mitotic chromosome condensation , 2015, eLife.

[7]  Marc Hafner,et al.  Fractional killing arises from cell-to-cell variability in overcoming a caspase activity threshold , 2015, Molecular Systems Biology.

[8]  Chuanfeng Wu,et al.  Development of an inducible caspase-9 safety switch for pluripotent stem cell–based therapies , 2014, Molecular therapy. Methods & clinical development.

[9]  Douglas B. Kell,et al.  How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion , 2014, Front. Pharmacol..

[10]  R. Krance,et al.  Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene. , 2014, Blood.

[11]  Siok-Keen Tey.  Adoptive T-cell therapy: adverse events and safety switches , 2014, Clinical & translational immunology.

[12]  D. Green,et al.  Mitochondrial regulation of cell death. , 2013, Cold Spring Harbor perspectives in biology.

[13]  Andrew M. K. Brown,et al.  Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer , 2013, Science.

[14]  H. Faneca,et al.  Suicide gene therapy in cancer: where do we stand now? , 2012, Cancer letters.

[15]  Alma L. Burlingame,et al.  Quantitative profiling of caspase-cleaved substrates reveals different drug-induced and cell-type patterns in apoptosis , 2012, Proceedings of the National Academy of Sciences.

[16]  J. Medema,et al.  Targeting colorectal cancer stem cells with inducible caspase-9 , 2012, Apoptosis.

[17]  E. Crawford,et al.  Caspase substrates and cellular remodeling. , 2011, Annual review of biochemistry.

[18]  D. Kulms,et al.  Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis , 2011, Oncogene.

[19]  Dani Setiawan,et al.  A first principles study of fluorescence quenching in rhodamine B dimers: how can quenching occur in dimeric species? , 2010, Physical chemistry chemical physics : PCCP.

[20]  H. Heslop,et al.  An Inducible Caspase 9 Suicide Gene to Improve the Safety of Mesenchymal Stromal Cell Therapies , 2010, Stem cells.

[21]  Ben S. Wittner,et al.  A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.

[22]  H. Heslop,et al.  An Inducible Caspase 9 Suicide Gene to Improve the Safety of Mesenchymal Stromal Cell Therapies. , 2009 .

[23]  P. Choyke,et al.  H-type dimer formation of fluorophores: a mechanism for activatable, in vivo optical molecular imaging. , 2009, ACS chemical biology.

[24]  P. Sorger,et al.  Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.

[25]  R. Milo,et al.  Dynamic Proteomics of Individual Cancer Cells in Response to a Drug , 2008, Science.

[26]  H. Heslop,et al.  Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[27]  K. Schulze-Osthoff,et al.  Apoptosis-based therapies and drug targets , 2005, Cell Death and Differentiation.

[28]  S. Srinivasula,et al.  Mechanism of XIAP-mediated inhibition of caspase-9. , 2003, Molecular cell.

[29]  Markus Rehm,et al.  Single-cell Fluorescence Resonance Energy Transfer Analysis Demonstrates That Caspase Activation during Apoptosis Is a Rapid Process , 2002, The Journal of Biological Chemistry.

[30]  X. Wang.  The expanding role of mitochondria in apoptosis. , 2001, Genes & development.

[31]  R. Matusik,et al.  Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer. , 2001, Cancer research.

[32]  T. Clackson,et al.  Intravenous Safety and Pharmacokinetics of a Novel Dimerizer Drug, AP1903, in Healthy Volunteers , 2001, Journal of clinical pharmacology.

[33]  Xiaoou Zhou,et al.  iCaspase 9 Suicide Gene System. , 2015, Methods in molecular biology.

[34]  W. Song,et al.  Ablation of microvessels in vivo upon dimerization of iCaspase-9 , 2002, Gene Therapy.